Boyu Su
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Microbiology top 10%
Papers in
-
- Nanoplatforms for cancer theranostics 11
- Oncology 8
- Pancreatic and Hepatic Oncology Research 5
- Cancer Cells and Metastasis 2
- Co-authors
- Chen Jiang (18 shared papers)Tao Sun (18 shared papers)Yifan Luo (10 shared papers)Zhenhao Zhao (11 shared papers)Qinjun Chen (15 shared papers)Zheng Zhou (9 shared papers)Yongchao Chu (10 shared papers)Peixin Liu (7 shared papers)
- Journals
- Advanced Materials (4 papers)ACS Nano (3 papers)Advanced Functional Materials (2 papers)Biomaterials (2 papers)Advanced Science (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Boyu Su
20 papers receiving 666 citations
Boyu Su's Hit Papers
Peers
Comparison fields: 5 of 79
- Biomaterials 119
- Microbiology 36
- Renewable Energy, Sustainability and the Environment 97
- Neurology 43
- Biomedical Engineering 218
Countries citing papers authored by Boyu Su
This map shows the geographic impact of Boyu Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyu Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyu Su more than expected).
Fields of papers citing papers by Boyu Su
This network shows the impact of papers produced by Boyu Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyu Su. The network helps show where Boyu Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Boyu Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 130 | |
| 2 | 2021 | 123 | |
| 3 | 2021 | 119 | |
| 4 | 2022 | 63 | |
| 5 | 2023 | 45 | |
| 6 | 2022 | 38 | |
| 7 | Engineered Bacterial Outer Membrane Vesicles‐Based Doxorubicin and CD47‐siRNA Co‐Delivery Nanoplatform Overcomes Immune Resistance to Potentiate the Immunotherapy of Glioblastoma Hit paper breakdown → | 2025 | 32 |
| 8 | 2021 | 26 | |
| 9 | 2022 | 24 | |
| 10 | 2025 | 19 | |
| 11 | 2024 | 16 | |
| 12 | 2023 | 13 | |
| 13 | 2024 | 7 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 3 | |
| 16 | 2025 | 3 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2022 | 1 |
About Boyu Su
Boyu Su is a scholar working on Biomedical Engineering, Oncology, Immunology, Molecular Biology and Biomaterials, having authored 22 papers that have together received 669 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (11 papers), Immune cells in cancer (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Phagocytosis and Immune Regulation (3 papers), Advanced Photocatalysis Techniques (2 papers), Cancer Cells and Metastasis (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Biomaterials (119 citations), Microbiology (36 citations), Renewable Energy, Sustainability and the Environment (97 citations), Neurology (43 citations) and Biomedical Engineering (218 citations). Boyu Su has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Chen Jiang, Tao Sun, Yifan Luo, Zhenhao Zhao, Qinjun Chen, Zheng Zhou, Yongchao Chu, Peixin Liu, Hongyi Chen and Tongyu Zhang. Their work appears in journals such as Advanced Materials, ACS Nano, Advanced Functional Materials, Biomaterials and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.